Paysign, Inc. (NASDAQ:PAYS – Get Free Report) major shareholder Daniel Spence sold 100,000 shares of the business’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $3.76, for a total transaction of $376,000.00. Following the completion of the transaction, the insider now owns 8,990,000 shares in the company, valued at $33,802,400. This represents a 1.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Paysign Price Performance
Shares of NASDAQ:PAYS traded down $0.04 during midday trading on Tuesday, reaching $2.48. The company had a trading volume of 717,053 shares, compared to its average volume of 273,926. The stock has a market capitalization of $132.80 million, a P/E ratio of 16.53 and a beta of 0.93. The stock’s fifty day moving average price is $2.67 and its 200-day moving average price is $3.25. Paysign, Inc. has a one year low of $2.25 and a one year high of $5.59.
Paysign (NASDAQ:PAYS – Get Free Report) last released its earnings results on Tuesday, March 25th. The company reported $0.02 earnings per share for the quarter, hitting the consensus estimate of $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. As a group, sell-side analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current year.
Hedge Funds Weigh In On Paysign
Analyst Upgrades and Downgrades
Separately, Lake Street Capital assumed coverage on Paysign in a research report on Friday, December 20th. They set a “buy” rating and a $6.00 target price on the stock.
Read Our Latest Research Report on PAYS
Paysign Company Profile
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Recommended Stories
- Five stocks we like better than Paysign
- What Are Treasury Bonds?
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Stock Analyst Ratings and Canadian Analyst Ratings
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Using the MarketBeat Stock Split Calculator
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.